BeOne Medicines
ONC
#647
Rank
ยฃ27.10 B
Marketcap
ยฃ244.91
Share price
1.11%
Change (1 day)
50.39%
Change (1 year)
BeOne Medicines formerly known as BeiGene, is a multinational pharmaceutical company engaged in the R&D, commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

Earnings for BeOne Medicines (ONC)

Earnings in 2025 (TTM): ยฃ0.13 Billion

According to BeOne Medicines's latest financial reports the company's current earnings are ยฃ4.97 Billion. In 2024 the company made an earning of -ยฃ0.43 Billion, an increase over its 2023 earnings that were of -ยฃ0.91 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for BeOne Medicines from 2015 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) ยฃ0.13 B-130.65%
2024 -ยฃ0.43 Billion-52.95%
2023 -ยฃ0.91 Billion-32.52%
2022 -ยฃ1.35 Billion24.39%
2021 -ยฃ1.08 Billion-13.21%
2020 -ยฃ1.25 Billion72.69%
2019 -ยฃ0.73 Billion36.01%
2018 -ยฃ0.53 Billion616.83%
2017 -ยฃ73.86 Million-15.24%
2016 -ยฃ87.15 Million107.91%
2015 -ยฃ41.92 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Onconova Therapeutics
ONTX
-ยฃ13.62 Million-109.94%๐Ÿ‡บ๐Ÿ‡ธ USA
OPKO Health
OPK
-ยฃ0.12 Billion-187.30%๐Ÿ‡บ๐Ÿ‡ธ USA